Keywords: genentech, expanding, product, portfolio, biotechnology, major, planning
GENENTECH'S EXPANDING PRODUCT PORTFOLIO
Article | 11 May 1992
Biotechnology major Genentech is planning to increase its research and development spending in 1992 to 50% of revenues, up from the 43% invested ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
